<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153047">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912690</url>
  </required_header>
  <id_info>
    <org_study_id>TRAINING</org_study_id>
    <nct_id>NCT01912690</nct_id>
  </id_info>
  <brief_title>The Influence of Different Training Regimens on Electrical Stability Following Myocardial Infarction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is that aerobic conditioning following acute heart attack will
      improve autonomic function and electrical stability of the heart.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Left ventrcular dyssynchrony</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by 2-D strain imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Autonomic function</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by Holter</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>standard of care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>aerobic training only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic and strength training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>aerobic training</intervention_name>
    <arm_group_label>aerobic training only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>aerobic and strength training</intervention_name>
    <arm_group_label>Aerobic and strength training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  s/p acute myocardial infarction 14-30 days

          -  ability to perform exercise

        Exclusion Criteria:

          -  unstable angina

          -  chronic atrial fibrillation

          -  severely reduced LV function

          -  NYHA 4

          -  severe valvular disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chaim Lotan, MD</last_name>
    <phone>972-2-6776563</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Leibowitz, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Leibowitz, MD</last_name>
      <email>oleibo@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>David Leibowitz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Horesh Dor Haim</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 30, 2013</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
